Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 8,726–8,750 of 27,380 studies, newest first · page 350 of 1096.

June 2022 25

  1. 2022-06-22

    Anticipated reactions to learning Alzheimer's disease biomarker results

    ✓ Peer-reviewed Disparities Alzheimer's research & therapy

    Key finding: Two models comprising behavior change and psychological impact fit well for the total sample and the two racial groups. +4 more findings

  2. 2022-06-22
  3. 2022-06-22

    Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease

    ✓ Peer-reviewed Biomarkers International journal of molecular sciences

    Key finding: Four CSF serpinA1 isoforms were differently expressed in AD patients compared to controls and LBD patients, especially isoforms 2 and 4. +2 more findings

  4. 2022-06-22

    Diagnosis of coexistent neurodegenerative dementias in multiple sclerosis

    ✓ Peer-reviewed Tau biomarkers Brain communications

    Key finding: Some multiple sclerosis patients present with severe cognitive impairment, and distinguishing multiple sclerosis-related cognitive impairment from co-existent progressive neurodegenerative diseases such as Alzheimer disease poses a diagnostic challenge. +3 more findings

  5. 2022-06-21

    Mouse Models of Alzheimer's Disease

    ✓ Peer-reviewed Inflammation and the immune system Frontiers in molecular neuroscience

    Key finding: The pathological hallmarks of AD are senile plaques and neurofibrillary tangles, which comprise abnormally aggregated β-amyloid peptide (Aβ) and hyperphosphorylated tau protein. +3 more findings

  6. 2022-06-21

    Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH

    ✓ Peer-reviewed TREM2 and immune genetics Journal of hepatology

    Key finding: & aims Previous single-cell RNA-sequencing analyses have shown that Trem2-expressing macrophages are present in the liver during obesity, non-alcoholic steatohepatitis (NASH) and cirrhosis. +3 more findings

  7. 2022-06-20

    Multimodal deep learning for Alzheimer's disease dementia assessment

    ✓ Peer-reviewed Digital health tools Nature communications

    Key finding: Here, we report a deep learning framework that accomplishes multiple diagnostic steps in successive fashion to identify persons with normal cognition (NC), mild cognitive impairment (MCI), AD, and non-AD dementias (nADD). +4 more findings

  8. 2022-06-18
  9. 2022-06-18

    LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions

    ✓ Peer-reviewed TREM2 and immune genetics Molecular neurodegeneration

    Key finding: Microglia plays crucial roles in Alzheimer's disease (AD) development. +3 more findings

  10. 2022-06-17

    Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia

    ✓ Peer-reviewed Inflammation and the immune system Molecular neurodegeneration

    Key finding: In the absence of effective therapeutic interventions, identifying risk factors associated with cognitive decline becomes increasingly vital. +3 more findings

  11. 2022-06-16

    Quality of end-of-life nursing home care in dementia: relatives' perceptions

    ✓ Peer-reviewed Health systems and care delivery BMJ supportive & palliative care

    Key finding: In total, 208 (response rate2010: 51.05%, response rate2015=60.65%) bereaved relatives responded to the questionnaire. +3 more findings

  12. 2022-06-16

    Are Brain and Cognitive Reserve Shaped by Early Life Circumstances?

    ✓ Peer-reviewed Risk factors Frontiers in neuroscience

    Key finding: Although neuropathological signs of dementia disorders can often be demonstrated in brains of patients, the degree to which clinical symptoms are present does mostly not accurately reflect the amount of neuropathology that is present. +2 more findings

  13. 2022-06-16

    Self-reported hearing loss, hearing aid use, and cognitive function among U.S. older adults

    ✓ Peer-reviewed Risk factors International journal of population studies

    Key finding: The purpose of this report is to examine how age-related changes in hearing loss and hearing aid use are associated with trajectories of cognitive function in a nationally-representative sample of U.S. older adults. +3 more findings

  14. 2022-06-16

    Insulin and insulin-like growth factor-I receptors in astrocytes exert different effects on behavior and Alzheimer´s-like pathology

    ✓ Peer-reviewed Biomarkers F1000Research

    Key finding: We observed that mice lacking IR in GFAP astrocytes (GFAP IR KO mice) develop mood disturbances and maintained intact cognition, while at the same time show greater pathology when cross-bred with APP/PS1 mice, a model of familial Alzheimer´s disease (AD). +2 more findings

  15. 2022-06-15

    Staging of Alzheimer's disease: past, present, and future perspectives

    ✓ Peer-reviewed Tau biomarkers Trends in molecular medicine

    Key finding: For many years Alzheimer's disease (AD) was associated with the dementia stage of the disease, the tail end of a pathophysiological process that lasts approximately two decades.

  16. 2022-06-15

    Microglial amyloid beta clearance is driven by PIEZO1 channels

    ✓ Peer-reviewed Genetics Journal of neuroinflammation

    Key finding: These results indicate that the compromised function of microglia in AD could be improved by controlled activation of PIEZO1 channels resulting in alleviated Aβ burden. +4 more findings

  17. 2022-06-15

    Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice

    ✓ Peer-reviewed Tau biomarkers Metabolic brain disease

    Key finding: Given the link between peripheral insulin resistance and tau pathology in streptozotocin-injected and db/db mouse models of diabetes, we fed high fat diet (HFD) to pR5 mice expressing P301L mutant human tau, with the aim of developing a new model with characteristics of obesity, T2DM and AD to mimic AD patients exacerbated by obesity and T2DM, an increasing trend in modern society. +3 more findings

  18. 2022-06-14

    Deprescribing Interventions by Palliative Care Clinical Pharmacists Surrounding Goals of Care Discussions

    ✓ Peer-reviewed End-of-life care Journal of palliative medicine

    Key finding: Eighty-two percent of recommendations were successfully implemented during hospitalization and included in the discharge plan. +3 more findings

  19. 2022-06-14

    Promoting activity in long-term care facilities with the social robot Pepper: a pilot study

    ✓ Peer-reviewed Health systems and care delivery Informatics for health & social care

    Key finding: After a series of interventions with the robot in a long-term care facility, data were collected through individual interviews with healthcare professional and residents. +4 more findings

  20. 2022-06-14

    Dementia and COVID-19 infection control in assisted living in seven states

    ✓ Peer-reviewed Health systems and care delivery Journal of the American Geriatrics Society

    Key finding: Less than half of administrators found it feasible to close indoor common areas, all community types reported a challenge organizing group activities for safe distancing, and more than half of residents with dementia did not wear a face covering or maintain physical distance from other residents when indicated. +3 more findings

  21. 2022-06-14

    Association of Visual, Hearing, and Dual Sensory Impairment With Incident Dementia

    ✓ Peer-reviewed Risk factors Frontiers in aging neuroscience

    Key finding: Among 113,511 participants (mean age: 56.8 ± 8.09 years, female: 54.4%), a total number of 1,135 (1.00%) cases of incident dementia were identified during a median follow up period of 11.1 years [interquartile range (IQR): 10.9-11.4 years]. +3 more findings

  22. 2022-06-14

    Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology

    ✓ Peer-reviewed Tau biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: A total of 96 proteins were decreased in MCI-SNAP compared to CN and MCI-AD. +4 more findings

  23. 2022-06-14

    Test-retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Clinical prediction models combining plasma biomarkers-particularly p-tau217-exhibit high performance and are less effected by random error.

  24. 2022-06-14

    Computerized cognitive training in Parkinson's disease: A systematic review and meta-analysis

    ✓ Peer-reviewed Prevention trials Ageing research reviews

    Key finding: The pooled effect of CCT relative to control was small and statistically significant for overall cognitive function (g=0.16; 95% CI 0.02-0.29). +3 more findings

  25. 2022-06-14

Browse the library by subject, with the full score breakdown →